Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
10.00
-0.05 (-0.50%)
At close: Jul 3, 2025, 1:00 PM
9.50
-0.50 (-5.00%)
After-hours: Jul 3, 2025, 4:54 PM EDT
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $531.78 million as of July 3, 2025. Its market cap has decreased by -42.96% in one year.
Market Cap
531.78M
Enterprise Value
218.96M
1-Year Change
-42.96%
Ranking
Category
Stock Price
$10.00
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has decreased from $654.64M to $531.78M, a decrease of -18.77%. That is a compound annual growth rate of -5.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 531.78M | -27.27% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 306.47B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 238.56B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |